EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Method for in vivo modulation of non-malignant skin-related processes with 9 cis-retinoic acid






Official Gazette of the United States Patent & Trademark Office Patents 1219(4): 3376, Feb 23

Method for in vivo modulation of non-malignant skin-related processes with 9 cis-retinoic acid


(PDF 0-2 workdays service: $29.90)

Accession: 035292692



Related references

Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro. Journal of Clinical Investigation 90(4): 1269-1274, 1992

Retinoic acid therapy of human skin in vivo stimulates cytochrome p 450 mediated transformation of retinoic acid into 4 hydroxy and 4 oxoretinoic acid which increase retinoic acid receptor dependent reporter gene transcription in vitro. Clinical Research 39(2): 472A, 1991

Soybean extract showed modulation of retinoic acid-related gene expression of skin and photo-protective effects in keratinocytes. International Journal of Cosmetic Science 35(2): 136-142, 2013

Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only Trans retinoic acid. Journal of Investigative Dermatology 106(2): 316-320, 1996

Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. Journal Of Investigative Dermatology. 105(4): 549-556, 1995

Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid. Official Gazette of the United States Patent & Trademark Office Patents 1210(2): 1560-1561, May 12, 1998

Topical retinoic acid in human skin in vivo induces expression of cellular retinol binding protein I but not alcohol dehydrogenase 3, although the promoters of both genes contain consensus retinoic acid response elements. Journal of Investigative Dermatology 100(4): 553, 1993

Molecular cloning of two human cellular retinoic acid binding proteins crabp retinoic acid induced expression of crabp ii but not crabp i in adult human skin in vivo and in skin fibroblasts in vitro. Journal of Biological Chemistry 266(26): 17662-17666, 1991

Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo. Journal Of Investigative Dermatology. 107(2): 183-187, 1996

Retinoic acid induces expression of PA-FABP (psoriasis-associated fatty acid-binding protein) gene in human skin in vivo but not in cultured skin cells. Experimental Dermatology 3(5): 212-218, 1994